Page last updated: 2024-08-25

nobiletin and imatinib mesylate

nobiletin has been researched along with imatinib mesylate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, PY; Chin, HK; Chuang, CH; Lin, CY; Wu, MJ; Yen, JH	1

Other Studies

1 other study(ies) available for nobiletin and imatinib mesylate

Article	Year
Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells. Cells, 2020, 04-03, Volume: 9, Issue:4 Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Differentiation; Cell Nucleus; Cell Proliferation; Early Growth Response Protein 1; Flavones; Gene Expression Regulation, Leukemic; Gene Ontology; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Megakaryocytes; RNA, Messenger; Up-Regulation	2020

Article

Year

Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.

Cells, 2020, 04-03, Volume: 9, Issue:4

Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Differentiation; Cell Nucleus; Cell Proliferation; Early Growth Response Protein 1; Flavones; Gene Expression Regulation, Leukemic; Gene Ontology; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Megakaryocytes; RNA, Messenger; Up-Regulation

2020